Name | IPN-60090 |
---|
Description | IPN-60090 is an orally bioavailable and selective inhibitor of GLS1 (the kidney-type glutaminase), an important enzyme for metabolic energy production. IPN-60090 can be used in the research of GLS1-mediated diseases[1][2]. |
---|---|
Related Catalog | |
Target |
GLS1[1] |
In Vitro | IPN-60090 (Example 1) has an IC50 against GLS1 and an EC50 against A549 cell proliferation of <100 nM[2]. |
References |
[1]. Maria Emilia Di Francesco, et al. Gls1 inhibitors for treating disease. WO2016004404A2. |
Molecular Formula | C24H27F3N8O3 |
---|---|
Molecular Weight | 532.52 |